medigraphic.com

2004, Number 2

<< Back

Rev Hosp Jua Mex 2004; 71 (2)

Hipoglucemia y acidosis láctica. Manifestación de linfoma no Hodgkin primario de ojo. Reporte de un caso y revisión de la bibliografía

Cisneros VSL, García VC, Herrera CMA

Language: Spanish
References: 26
Page: 86-91
PDF size: 530.92 Kb.


ABSTRACT

Intraocular non-Hodgkin’s lymphoma and the central nervous system (CNS) are few commons presentations; in the most of cases, it has associated presentation. In the medical literature, there are few cases reported with hypoglycaemia and lactic acidosis. So, we report the case about a 49 years old woman, who was hospitalized in the Internal Medicine Department of Hospital Juárez de México, SS. She was admitted for general state worsening, visuals disorders, hypoglycaemia and lactic acidosis refractory to treatment. We concluded primary non-Hodgkin’s lymphoma of left eye. She died 24 hours after chemotherapy beginning.


REFERENCES

  1. Forsythe SM, Schmidt GA. Sodium bicarbonate for the treatment of lactic acidosis. CHEST 2000; 117: 260-7.

  2. Sillos EM, Sheenep JL, Burghen GA, Pui Ching-Hon, Behm FG, Sandlund JT. Lactic acidosis: a metabolic complication of hematologic malignancies. Cancer 2001; 92: 2237-46.

  3. Field M, Block JB, Levin R, Rall DP. Significance of blood lactate elevations among patients with acute leukemia and other neoplastic proliferative disorders. Am J Med 1966; 40: 528-47.

  4. Deyrin D, Balko Ch. Glucose-lactate inter-relations in man. NEJM 1972; 287(3): 132-7.

  5. Goodgame J. Thomas, Pizzo Jr. Phillip, Brennan MF. Iatrogenic lactic acidosis. Cancer 1978; 42: 800-3.

  6. Sans-Sabrafen J, Besses RC. Vives CJL, Castillo CR, Woessner CS. Linfoma no Hodgkin. Hematología clínica. Harcourt 2002: 439-84.

  7. Cortina P, Navea A, Díaz M. Linfoma intraocular y otros tumores. http://www.oftalmo.com/sida/CAP49.HTM

  8. Char DH, Ljung Britt-Marie, Miller T, Phillips T. Primary intraocular lymphoma (ocular reticulum cell sarcoma). Diagnosis and management. Ophthalmology 1988; 95: 625-30.

  9. Whitcup SM, De Smet MD, Rubin BI, Palestine AG, Martin DF, Burnier MJr, et al. Intraocular lymphoma. Clinical and histopathologic diagnosis. Ophthalmology 1993; 100: 1399- 406.

  10. López JS, Chan Chi-Chao, Burnier M, Rubin B, Nussenblatt RB. Immunohistochemistry findings in primary intraocular lymphoma. Am J Ophthalmology 1991; 112(4): 472-4.

  11. A. Adán. Cirugía vitreorretiniana y uveítis. http:// www.oftalmored.com/vitreorretiniana/capitulo16.htm

  12. Wilson DJ, Braziel R, Rosenbaum J. Intraocular lymphoma. Immunopathologic analysis of vitreous biopsy specimens. Arch Ophthalmol 1992; 110: 1455-8.

  13. Char DH, Ljung Britt-Marie, Deschénes J, Miller TR. Intraocular lymphoma: immunological and cytological analysis. B J Ophthalmology 1988; 72: 905-11.

  14. Giles FJ, Vose JM, Do Kim-Anh, Johnson MM, Manshouri T, Bociek G, et al. Circulating CD20 and CD52 in patients with non-Hodgkin’s lymphoma or Hodgkin’s disease. B J Haematology 2003; 123: 850-7.

  15. Dávila RM. Biopia por aspiración con aguja fina de tumores intraoculares. conganat.uninet.edu/IVCVHAP/CONFERENCIAS/ Davila

  16. Finger P, Saornil M, Vecilla G. Linfoma introocular. Eye cancer network. pfinger@eyecancer.com.

  17. Hollender A, Kvaloy S, Nome O, Skovlund E, Lote K, Holte H. Central nervous system involvement following diagnosis of non-Hodgkin’s lymphoma: a risk model. Annals of Oncology 2002; 13: 1099-107.

  18. Balzarotti M, Spina M, Sarina B, Magagnoli M, Castagna L, Milan I, et al. Intensified CHOP regimen in aggressive lymphomas: maximal dose intensity and dose density of doxorubicin and cyclophosphamide. Annals of Oncology 2002; 13: 1341-6.

  19. Emmanouilides C, Territo M, Menco H, Patel R, Rosen P. Mitoxantrone-cyclophosphamide-rituximab: an effective and safe combination for indolent NHL. Hematological Oncology 2003; 21: 99-108.

  20. Martinelli G, Laszlo D, Bertolini F, Pastano R, MP, Calleri A, et al. Chlorambucil in combination with induction and maintenance rituximab is feasible and active in indolent non- Hodgkin’s lymphoma. BJ Haematology 2003; 123: 271-7.

  21. Zelenetz AD, Hamlin P, Kewalramani T. Ifosfamide, carboplatin, etoposide (ICE)-based second-line chemotherapy for the management of relapsed and refractory aggressive non- Hodgkin’s lymphoma. Annals of Oncology 14 (Suppl. 1): i5- i10, 2003.

  22. Di Comité G, Dagna L, Piatti PM, Monti LD, Tantardini F, Praderio L. Hypoglycaemia and lactic acidosis in a MALT non Hodgkin’s lymphoma. Leuk lymphoma 2002; 43(4): 1341-2.

  23. Nadiminti Y, Wang JC, Chou Shyan-yih, Pineles E, Tobin MS. Lactic acidosis associated with Hodgkin’s disease. NEJM 1980; 303(1): 15-17.

  24. Fields ALA, Wolman SL(+), Halperin ML. (+). Chronic lactic acidosis in a patient with cancer: therapy and metabolic consequences. Cancer 1981; 47: 2026-9.

  25. Fraley DS, Adler Sh, Bruns FJ, Zett B. Stimulation of lactate production by administration of bicarbonate in a patient with a solid neoplasm and lactic acidosis. NEJM 1980; 6: 1100-2.

  26. Knowles DM, Jakobiec FA, McNally L, Burke JS. Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa orbit, conjunctiva, and eyelids: a prospective multiparametric analysis of 108 cases during 1977 to 1987. Human Pathology 1990; 21(9): 959-73.




2020     |     www.medigraphic.com